did the fda ban tirzepatide will reconsider decision barring copycat versions of Lilly weight loss drug The FDA's Decision to Ban

Tirzepatide must be discarded under several specific circumstances to ensure patient safety and therapeutic effectiveness

In the realm of peptides for healing , compounds like BPC-157 and TB-500 are frequently discussed for their possible ability to support tissue health

You are ready to go again

What to know about new study showing weight loss drugs can lower cancer risk GLP-1 medications such as Ozempic and Wegovy have exploded in popularity for their weight loss benefits and now new research is showing the medications may help with another condition, cancer

Levels are also reduced in chronic kidney disease, making klotho a biomarker of renal function as well as aging